The
Wegovy is now the first once-weekly weight loss drug approved for adolescents
The FDA has approved the drug Wegovy (semaglutide) treat obesity in children
Pediatric obesity is an exponentially growing global public health concern
Emmalea Zummo was one of 201 adolescents, ages 12 to 17, who received once-weekly injections of the obesity drug semaglutide
Kids (IWQOL-Kids) questionnaire total
Semaglutide is a glucagon-like peptide-1 (GLP-1) agonist How should I take semaglutide? Wegovy and Ozempic are given as a subcutaneous injection once a
It mimics the GLP-1 hormone, released in the
You might recognize Semaglutide by its brand names like Ozempic and Wegovy
Emmalea Zummo was one of 201 adolescents, ages 12 to 17, who received once-weekly injections of the obesity drug semaglutide
Semaglutide is a glucagon-like peptide-1 (GLP-1) agonist
Compared to just 12% of 67 teenagers receiving a placebo or dummy shot, 45% of 133 adolescents taking semaglutide changed BMI groups in a study
to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes with known heart disease
The effect of semaglutide 2
Hailed as a "game-changer," it works by curbing appetite and can make people's cravings disappear Semaglutide is a drug that stimulates insulin production and can help manage weight
4 million children and adolescents is affected by obesity,1,2 making it one of the most common pediatric chronic diseases
These additions may be advertised as helping to make semaglutide work better or lessen side effects
1,20,21,27 In the Wegovy contains semaglutide, which is the same active ingredient in Ozempic and Rybelsus, therefore these products should not be used together
after I had my kids," she says
4 mg as compared with placebo in patients with heart failure with preserved ejection fraction, obesity, and type 2 Do not use different brands of semaglutide (Wegovy or Rybelsus) at the same time